Similar articles for PMID: 33820860

Year	Number of Results
1998	2
1999	3
2000	3
2001	1
2002	1
2003	1
2004	2
2005	3
2006	4
2007	2
2008	4
2009	3
2010	2
2011	5
2012	6
2013	6
2014	5
2015	4
2016	7
2017	6
2018	10
2019	10
2020	13
2021	11
2022	1
2023	0

1

Nuclear Medicine and Molecular Imaging in Nodal Staging and Surveillance of Ocular Melanoma: Case Reports and Review of the Literature.

Zurcher KS, Houghton OM, Shen JF, Seetharam M, Roarke MC, Yang M. Zurcher KS, et al. J Nucl Med Technol. 2021 Sep;49(3):275-280. doi: 10.2967/jnmt.120.260539. Epub 2021 Apr 5. J Nucl Med Technol. 2021. PMID: 33820860 Free article. Review.

2

F-18 fluorodeoxyglucose positron emission tomography/computed tomography in conjunctival melanoma with recurrence.

Jain A, John AR, Kishore B, Vishnoi MG, Pandit AG, Sharma A, Jaimini A, Jain M, Singh A. Jain A, et al. J Cancer Res Ther. 2020 Dec;16(Supplement):S240-S242. doi: 10.4103/jcrt.JCRT_453_17. J Cancer Res Ther. 2020. PMID: 33380688 Free article.

3

Rational use of ¹⁸F-FDG PET/CT in patients with advanced cutaneous melanoma: A systematic review.

Bisschop C, de Heer EC, Brouwers AH, Hospers GAP, Jalving M. Bisschop C, et al. Crit Rev Oncol Hematol. 2020 Sep;153:103044. doi: 10.1016/j.critrevonc.2020.103044. Epub 2020 Jul 1. Crit Rev Oncol Hematol. 2020. PMID: 32673997 Free article. Review.

4

Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.

Freudenberg LS, Schueler AO, Beyer T, Antoch G, Kühl H, Bornfeld N, Bockisch A, Egelhof T. Freudenberg LS, et al. Surv Ophthalmol. 2004 Sep-Oct;49(5):537-40. doi: 10.1016/j.survophthal.2004.06.008. Surv Ophthalmol. 2004. PMID: 15325198

5

The value of lymph node ultrasound and whole body ¹⁸F-FDG PET/CT in stage IIB/C melanoma patients prior to SLNB.

Stahlie EHA, van der Hiel B, Bruining A, van de Wiel B, Schrage YM, Wouters MWJM, van Houdt WJ, van Akkooi ACJ. Stahlie EHA, et al. Eur J Surg Oncol. 2021 May;47(5):1157-1162. doi: 10.1016/j.ejso.2020.12.007. Epub 2021 Jan 19. Eur J Surg Oncol. 2021. PMID: 33353826

6

Clinical Value of PET/CT in Staging Melanoma and Potential New Radiotracers.

Annunziata S, Laudicella R, Caobelli F, Pizzuto DA, Aimn Working Group Y. Annunziata S, et al. Curr Radiopharm. 2020;13(1):6-13. doi: 10.2174/1874471012666191015094620. Curr Radiopharm. 2020. PMID: 31749438 Review.

7

Clinical and Prognostic Value of ¹⁸F-FDG-PET/CT in the Restaging Process of Recurrent Cutaneous Melanoma.

Albano D, Familiari D, Fornito MC, Scalisi S, Laudicella R, Galia M, Grassedonio E, Ruggeri A, Ganduscio G, Messina M, Spada M, Midiri M, Alongi P. Albano D, et al. Curr Radiopharm. 2020;13(1):42-47. doi: 10.2174/1874471012666191009161826. Curr Radiopharm. 2020. PMID: 31595860

8

The role of FDG-PET-CT is limited in initial staging of nodal metastasis for thin cutaneous melanoma.

Cheng D, McNicoll CF, Kirgan D, Jones MS, Rivera MR, Doyle GM, De Guzman MD, Baynosa J, St Hill CR. Cheng D, et al. Am J Surg. 2021 Apr;221(4):737-740. doi: 10.1016/j.amjsurg.2020.03.031. Epub 2020 Apr 7. Am J Surg. 2021. PMID: 32354604

9

Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?

Schaarschmidt BM, Grueneisen J, Stebner V, Klode J, Stoffels I, Umutlu L, Schadendorf D, Heusch P, Antoch G, Pöppel TD. Schaarschmidt BM, et al. Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2093-2102. doi: 10.1007/s00259-018-4061-9. Epub 2018 Jun 6. Eur J Nucl Med Mol Imaging. 2018. PMID: 29876618

10

[Role of FDG PET-CT in cutaneous melanoma].

Nicol I, Chuto G, Gaudy-Marqueste C, Brenot-Rossi I, Grob JJ, Richard MA. Nicol I, et al. Bull Cancer. 2008 Nov;95(11):1089-101. doi: 10.1684/bdc.2008.0745. Bull Cancer. 2008. PMID: 19036682 Free article. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed